Subscribe to RSS
DOI: 10.1055/s-2001-11505
© Georg Thieme Verlag Stuttgart · New York
Piperine Inhibits Gastric Emptying and Gastrointestinal Transit in Rats and Mice
Publication History
February 29, 2000
July 2, 2000
Publication Date:
31 December 2001 (online)
![](https://www.thieme-connect.de/media/plantamedica/200102/lookinside/thumbnails/10.1055-s-2001-11505-1.jpg)
Abstract
Piperine (1), an alkaloid of black and long peppers, inhibited gastric emptying (GE) of solids/liquids in rats and gastrointestinal transit (GT) in mice in a dose and time dependent manner. Compound 1 significantly inhibited GE of solids and GT at the doses extrapolated from humans (1 mg/kg and 1.3 mg/kg p.o. in rats and mice, respectively). However, at the same dose the effect was insignificant for GE of liquids. One week oral treatment of 1 mg/kg and 1.3 mg/kg in rats and mice, respectively, did not produce a significant change in activity as compared to single dose administration. GE inhibitory activity of 1 is independent of gastric acid and pepsin secretion.
References
- 1 Atal C K, Zutshi U, Rao P G. Scientific evidence of the role of Ayurvedic herbals on bioavailability of drugs. J. Ethnopharmacol.. 1981; 4 229-32
- 2 Bano G, Raina R K, Zutshi U, Bedi K L, Johri R K, Sharma S C. The effect of piperine on bioavailability and pharmacokinetics of propranolol and theophylline in healthy volunteers. Eur. J. Clin. Pharmacol.. 1991; 41 615-7
-
3 Majeed M, Badmaev V, Ramaswamy R.
Use of piperine as a bioavailability enhancer . US Patent No. 5,744,161 1998 - 4 Bano G, Amla V, Raina R K, Zutshi U, Chopra C L. The effect of piperine on pharmacokinetis of phenytoin in healthy volunteers. Planta Medica. 1987; 53 568-9
-
5 Kapil R S, Zutshi U, Bedi K L, Singh G, Johri R K, Dhar S K et al.
A process for the preparation of pharmaceutical combination with enhanced activity for the treatment of tuberculosis and leprosy . US Patent No. 5439891 1995 -
6 Bedi K L, Zutshi U, Kapoor N, Koul J L, Bano G.
A process for the preparation of pharmacetuical combination with enhanced activity for the treatment of vitiligo, psoriasis, mycosis and fungoides . Indian Patent No. 176433 1993 - 7 Atal C K, Dubey R K, Singh J. Biochemical basis of enhanced drug bioavailability by piperine: Evidence that piperine is a potent inhibitor of drug metaoblism. J. Pharm. Exp. Ther.. 1985; 232 258-62
-
8 Gibaldi M.
Biopharmaceutics and Clinical pharmacokinetics . Philadelphia; Lea and Febiger 1984: 35-8 - 9 Minami H, McCallum R W. The physiology and pathophysiology of gastric emptying in humans. Gastroenterology. 1984; 86 1592-610
- 10 Bertaccini G, Scarpignato C. Effect of some cholecystokinin (CCK) - like peptides on gastric emptying of a liquid meal in rat. Bri. J. Pharmacol.. 1981; 72 103P-104P
- 11 Hunt J N, MacDonald I. The pattern of emptying of human stomach. J. Physiol. (London). 1954; 126 459-74
- 12 Annamalai A R, Manavalan R. Effect of “trikatu” and its individual components and piperine on gastrointestinal tracts: Trikatu - A bioavailability enhancer. Indian Drugs. 1989; 27 595-604
- 13 Glatzel H. Physiological aspects of flavour compounds. Indian Spices.. 1968; 5 13
- 14 Cole O F. Pharmacological studies of piperine; I. Effects of piperine on transmural nerve stimulation. Planta Medica. 1985; 51 153-6
- 15 Bhat G B, Chandrashekhara N. Studies on the metabolism of piperine: Absorption, tissue distribution and excretion of urinary conjugates in rats. Toxicology. 1986; 40 83-92
- 16 Bertaccini G, Castiglone De, Scarpignato C. Effect of substance P and its analogues on the gastric emptying of the conscious rat. Br. J. Pharmacol.. 1981; 72 221-3
- 17 Garcia-Garayoa E, Monge A, Roca J, Del Rio J, Lasheras B. VB20B7, a novel 5-HT-ergic agent with gastrokinetic activity. II. Evaluation of the gastroprokinetic activity in rats and dogs. J. Pharm. Pharmacol.. 1997; 49 66-73
- 18 Bhattacharjee M, Bose A K, Banerjee R K. Histamine H2-receptor mediated stimulation of gastric acid secretion by mercaptomethylimidazole. Biochem. Pharmacol.. 1989; 381 907-14
Dr. K. L. Bedi
Chairman
Pharmacology Division
Regional Research Laboratory
Canal Road
Jammu 180 001
India
Email: rrlj@nde.vsnl.net.in or sbajad@yahoo.com